{"url_path":"/sec/rmtg/10-k/2026/item-12","section_key":"item-12","section_title":"Item 12 **","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1760026/0001213900-26-056841-index.html","accession_number":"0001213900-26-056841","cik":"0001760026","ticker":"RMTG","issuer_name":"Regenerative Medical Technology Group Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1760026/0001213900-26-056841-index.html","primary_entity_key":"0001760026","primary_entity_name":"Regenerative Medical Technology Group Inc."},"word_count":381,"has_tables":true,"body_markdown":"**ITEM 12.**\n**SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.**\n\n \n\nThe following table sets forth the number of shares\nof common stock owned of record and beneficially by our executive officers, directors and persons who hold 5% or more of the outstanding\nshares of voting stock of the Company.\n\n \n\nThe amounts and percentages of our common stock\nbeneficially owned are reported on the basis of SEC rules governing the determination of beneficial ownership of securities. Under the\nSEC rules, a person is deemed to be a “beneficial owner” of a security if that person has or shares “voting power,”\nwhich includes the power to vote or to direct the voting of such security, or “investment power,” which includes the power\nto dispose of or to direct the disposition of such security. A person is also deemed to be a beneficial owner of any securities of which\nthat person has the right to acquire beneficial ownership within 60 days through the exercise of any stock option, warrant or other right.\nUnder these rules, more than one person may be deemed a beneficial owner of the same securities, and a person may be deemed to be a beneficial\nowner of securities as to which such person has no economic interest. Unless otherwise indicated, each of the shareholders named in the\ntable below, or his or her family members, has sole voting and investment power with respect to such shares of our common stock. Except\nas otherwise indicated, the address of each of the shareholders listed below is c/o Regenerative Medical Technology Group Inc., 433 Plaza\nReal Suite 275 Boca Raton, Florida 33432.\n\n \n\nApplicable percentage ownership is based on 13,138,968\nshares of Common Stock outstanding as of May 14, 2026. In addition, as of May 14, 2026, there were 1,050,000 shares of Series AA Preferred\nStock outstanding.\n\n \n\nName and Address of Beneficial Owner \nCommon\n\nStock\n\nOwned\n\nBeneficially  \nPercent\n\nof Class  \nSeries AA\n\nPreferred\n\nStock\n\nOwned\n\nBeneficially  \nPercent\n\nof Class \n\nNamed Executive Officers and Directors \n   \n   \n   \n  \n\nDave Christensen \n    \n    \n 50,000  \n 5%\n\nAll Executive Officers and Directors as a group (1 person) \n    \n    \n 50,000  \n 5%\n\n5% or greater shareholders \n    \n    \n    \n   \n\nAjene Watson LLC and Digital Asset Monetary Network (1) \n 1,082,477  \n 8.7% \n    \n   \n\nBenito Novas \n    \n    \n 1,000,000  \n 95%\n\n \n\n(1)Mr.\nAjene Watson has investment and voting control over such shares."}